よむ、つかう、まなぶ。
参考資料15 COVID-19 vaccine safety update; Primary series in young children and booster doses in older children and adults, ACIP September 1, 2022 (33 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000208910_00052.html |
| 出典情報 | 第85回厚生科学審議会予防接種・ワクチン分科会副反応検討部会、令和４年度第14回薬事・食品衛生審議会薬事分科会医薬品等安全対策部会安全対策調査会（合同開催）（10／7）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
VSD signals for pre-specified outcomes in 21-day risk interval after 1st booster in people
ages 12 years and older
Results through
Aug 13, 2022
* Analyses not yet
possible
Primary series with
Pfizer-Pfizer OR
Moderna-Moderna
Signal after 1st booster
Pfizer-Pfizer
Moderna-Moderna
Pfizer OR Moderna
Pfizer
Signal?
Moderna
Acute disseminated encephalomyelitis
No
No
-*
Acute myocardial infarction
No
No
No
Appendicitis
No
No
No
Bell's palsy
No
No
No
Cerebral venous sinus thrombosis
No
No
No
Disseminated intravascular coagulation
No
No
No
Encephalitis / myelitis / encephalomyelitis
No
No
No
Guillain-Barre syndrome
No
No
No
Stroke, hemorrhagic
No
No
No
Stroke, ischemic
No
No
No
Immune thrombocytopenia
No
No
No
Myocarditis / pericarditis
Yes
No
No
Seizures
No
No
No
Transverse myelitis
No
No
No
Thrombotic thrombocytopenic purpura
No
No
No
Thrombosis with thrombocytopenia syndrome
No
No
No
Venous thromboembolism
No
No
No
Pulmonary embolism
No
No
No
VSD RCA pre-specified outcomes
33
ages 12 years and older
Results through
Aug 13, 2022
* Analyses not yet
possible
Primary series with
Pfizer-Pfizer OR
Moderna-Moderna
Signal after 1st booster
Pfizer-Pfizer
Moderna-Moderna
Pfizer OR Moderna
Pfizer
Signal?
Moderna
Acute disseminated encephalomyelitis
No
No
-*
Acute myocardial infarction
No
No
No
Appendicitis
No
No
No
Bell's palsy
No
No
No
Cerebral venous sinus thrombosis
No
No
No
Disseminated intravascular coagulation
No
No
No
Encephalitis / myelitis / encephalomyelitis
No
No
No
Guillain-Barre syndrome
No
No
No
Stroke, hemorrhagic
No
No
No
Stroke, ischemic
No
No
No
Immune thrombocytopenia
No
No
No
Myocarditis / pericarditis
Yes
No
No
Seizures
No
No
No
Transverse myelitis
No
No
No
Thrombotic thrombocytopenic purpura
No
No
No
Thrombosis with thrombocytopenia syndrome
No
No
No
Venous thromboembolism
No
No
No
Pulmonary embolism
No
No
No
VSD RCA pre-specified outcomes
33